The University of California Berkeley spin-out raises $75m for collaboration projects
Amyris, a synthetic biology specialist, has announced the pricing of $75m senior convertible notes. The notes will mature on May 15, 2019. Amyris is granting the initial buyer an option to purchase up to an additional $15m. Morgan Stanley is acting as initial purchaser and sole book-running manager for the offering of the notes.
The notes will be convertible at any time at the option of holders up until May 14, 2019. Upon conversion, the notes will be settled…
